Cognitive function and fine motor speed in older women with diabetes mellitus: Rresults from the women's health initiative study of cognitive aging

Journal of Women's Health

Volumn 20, Issue 10, 2011, Pages 1435-1443

  Espeland, Mark A ^a   Miller, Michael E ^a   Goveas, Joseph S ^b   Hogan, Patricia E ^a   Coker, Laura H ^c   Williamson, Jeff ^c   Naughton, Michelle ^c   Resnick, Susan M ^d  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; INSULIN; ORAL ANTIDIABETIC AGENT; PLACEBO;

AGED; AGING; ARTICLE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FINE MOTOR SPEED; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MOTOR PERFORMANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERBAL MEMORY; WOMEN'S HEALTH;

AGED; AGED, 80 AND OVER; AGING; COGNITION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LINEAR MODELS; PSYCHOMOTOR PERFORMANCE;

EID: 80053986748     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.2812     Document Type: Article

References (45)

1. Strachan MW, Deary IJ, Ewing FM, Frier BM. Is type II diabetes associated with an increased risk of cognitivedysfunction? A critical review of published studies. Diabetes Care 1997;20:438-445. (Pubitemid 27098239)
2. Leibson CL, Rocca WA, Hanson VA, et al. Risk of dementia among persons with diabetes mellitus: A population-based cohort study. Am J Epidemiol 1997;145:301-308. (Pubitemid 27082028)
3. Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res 2009;1280:186-194.
4. Fischer AL, de Frias CM, Yeung SE, Dixon RA. Short-term longitudinal trends in cognitive performance in older adults with type 2 diabetes. J Clin Exp Neuropsychol 2009;31: 809-822.
5. Yeung SE, Fischer AL, Dixon RA. Exploring effects of type 2 diabetes on cognitive function in older adults. Neuropsychology 2009;23:1-9.
6. van den Berg R, Reijmer YD, de Bresser J, Kessels RPC, Kappelle LJ, Biessels GJ. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes. Diabetologia 2010;53:58-65.
7. Araki A, Ito H. Diabetes mellitus and geriatric syndromes. Geriatr Gerontol Int 2009;9:105-114.
8. van den Berg E, Kloppenborg RP, Kessels RP, Kapelle LJ, Biessels GJ. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comarison of their impact on cognition. Biochim Biophys Acta 2009;1792: 470-481.
9. Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas R. Diabetes is associated with a slower rate of cognitive decline in Alzheimer's disease. Neurology 2009;73:1259-1366.
10. Ravona-Springer R, Luo X, Schmeidler J, et al. Diabetes is associated with increased rate of cognitive decline in questionably demented elderly. Dement Geriatr Cogn Disord 2010;29:68-74.
11. Nooyens AC, Baan CA, Spjikerman AM, Verschuren WM. Type 2 diabetes and cognitive decline in middle-aged men and women: The Doetinchem Cohort Study. Diabetes Care 2010;33:1964-1969.
12. Shumaker SA, Reboussin BA, Espeland MA, et al. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998;19: 604-621. (Pubitemid 29057725)
13. Resnick SM, Coker LH, Maki PM, Rapp SR, Espeland MA, Shumaker SA. The Women's Health Initiative Study of Cognitive Aging (WHISCA): A randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials 2004;1:440-450.
14. Resnick SM, Maki PM, Rapp SR, et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metabol 2006;91:1802-1810.
15. Resnick SM, Espeland MA, An Y, et al. Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy. J Clin Endocrinol Metab 2009;94:4152-4161.
16. Espeland MA, Brunner RL, Hogan PE, et al. Long-term effects of conjugated equine estrogens therapies on domainspecific cognitive function: Results from the Women's Health Initiative Study of Cognitive Aging Extension. J Am Geriatr Soc 2010;58:1263-1271.
17. Margolis KL, Qi L, Brzyski R, et al. Validity of diabetes selfreports in the Women's Health Initiative: Comparison with medication inventories and fasting glucose measurements. Clin Trials 2008;5:240-247.
18. Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988;26:775-789.
19. McTiernan A, Cooperberg C, White E, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women. JAMA 2003;290:1331-1337.
20. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed models. Cary, NC: SAS Institute, Inc., 1996.
21. Tiehuis AM, van der Graaf Y, Visseren FL, et al. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic vascular disease. Stroke 2008;39:1600-1603.
22. Luchsinger JA, Gustafson DR. Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimer's Dis 2009;16:693-704.
23. Zhou H, Lu W, Shi Y, et al. Impairments in cognition and resting-state connectivity of the hippocampus in elderly subjects with type 2 diabetes. Neurosci Lett 2010;473:5-10.
24. Sims-Robinson C, Kim B, Rosko A, Feldman AL. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 2010;6:551-559.
25. Desai AK, Grossberg GT, Chibnall JT. Healthy brain aging: A road map. Clin Geriatr Med 2010;26:1-16.
26. Strachan MW, Reynolds RM, Frier BM, Mitchell RJ, Price JF. The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes: Implications for future therapeutics strategies. Diabetes Obes Metab 2009;11:407-414.
27. Marioni RE, Strachan MWJ, Reynolds RM, et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes. Diabetes 2010;59: 710-713.
28. Williamson JD, Miller ME, Bryan N, et al. The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): Rationale, design, and methods. Am J Cardiol 2007;99:112i-122i.
29. Steffens DC, Otey E, Alexopoulos GS, et al. Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry 2006;63:130-138. (Pubitemid 43213874)
30. Cukierman-Yaffe T, Gerstein HC, Williamson JD, et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors. Diabetes Care 2009;32:221-226.
31. van Harten B, Oosterman J, Muslimovic D, van Loon BJ, Scheltens P, Weinstein HC. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 2007;36:164-170. (Pubitemid 46455395)
32. Biessels GJ, Dreary IJ, Ryan CM. Cognition and diabetes: A lifespan perspective. Neurology Lancet 2008;7:184-190.
33. Lamport DJ, Lawton CL, Mansfield MW, Dye L. Impairments in glucose tolerance can have a negative impact on cognitive function: A systematic research review. Neurosci Biobehav Rev 2009;33:394-413.
34. Rasgon NL, Kenna HA, Wroolie TE, et al. Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Neurobiol Aging 2009. doi:10.1016/j.neurobiolaging .2009.12.005.
35. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson S, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 2010 do1:10.1001/archneurol.2010.225.
36. McEwen BS. Possible mechanisms for atrophy of the human hippocampus. Mol Psychiatry 1997;2:255-263.
37. Convit A. Link between cognitive impairment in insulin resistance: An explanatory model. Neurobiol Aging 2005;26:S31-S35. (Pubitemid 41739422)
38. Grober E, Hall CB, Lipton RB, Zonderman AB, Resnick SM, Kawas C. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2008;14:266-278. (Pubitemid 351280005)
39. Adlam AL, Bozeat S, Arnold R, Watson P, Hodges JR. Semantic knowledge in mild cognitive impairment and mild Alzheimer's disease. Cortex 2006;42:675-684. (Pubitemid 44083566)
40. Roriz-Filho JS, Sa-Roriz TM, Rosset I, et al. Prediabetes, brain aging, and cognition. BiochimBiophysActa 2009;1792:432-443.
41. Luchsinger JA. Insulin resistance, type 2 diabetes, and AD. Neurology 2010;75:758-759.
42. Matsuzaki T, Sasaki K, Tanizaki Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease. Neurology 2010;75:764-770.
43. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/ EDIC) Study Research Group. New Engl J Med 2007;356:1842-1852.
44. Ryan CM, Freed MI, Rood JA, et al. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 2006;29:345-351. (Pubitemid 44106516)
45. Plastino M, Fava A, Pirritano D, et al. Effects of insulin therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. J Neurol Sci 2010;288:112-116.